logo

For the Inventor, By the Inventor

GB

Circassia Limited


USPTO Granted Patents = 19



Trademarks = 2

Forward Citations = 31

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Roderick Peter Hafner (14 out of 29 patents)

silverMedal Paul Laidler (12 out of 12 patents)

bronzeMedal Mark Larche (12 out of 12 patents)

4.  Anthony Barrington Kay (3 out of 3 patents)

5.  Robyn Elizabeth O'Hehir (2 out of 10 patents)

6.  Jennifer May Rolland (2 out of 8 patents)

7.  Guy Layton (2 out of 2 patents)

8.  James Robinson (1 out of 5 patents)

9.  Pascal Hickey (1 out of 1 patent)

10.  Imre Farkas (1 out of 1 patent)

11.  Graham Ruecroft (1 out of 6 patents)

12.  Dipesh Parikh (5 patents)

13.  Simon Ball (1 patent)

14.  Paul Laider (0 patent)

15.  Rod Hafner (0 patent)


19 patents:

1. 10143991 - Process for making crystals (2018-12-04),
2. 9850281 - Cladosporium peptides (2017-12-26),
3. 9744222 - Peptide for vaccine (2017-08-29),
4. 9657061 - Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy (2017-05-23),
5. 9375470 - Compositions with reduced dimer formation (2016-06-28),
6. 9347937 - Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy (2016-05-24),
7. 9340580 - Peptide with multiple epitopes (2016-05-17),
8. 9180098 - Compositions with reduced dimer formation (2015-11-10),
9. 9168295 - Vaccine peptide combinations (2015-10-27),
10. 9120865 - T cell epitopes of the Cyn d 1 allergen from bermuda grass pollen (2015-09-01),
11. 9017689 - Peptides for vaccine against birch allergy (2015-04-28),
12. 8821887 - T-cell antigen peptide from allergen for stimulation of IL-10 production (2014-09-02),
13. 8753644 - Grass peptides for vaccine (2014-06-17),
14. 8652485 - Peptide for vaccine (2014-02-18),
15. 8551493 - Peptide with reduced dimer formation (2013-10-08),
Circassia Limited is a specialty pharmaceutical company focused on developing and commercializing innovative solutions for the treatment of respiratory diseases. They are committed to improving the lives of patients with a range of respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. With a strong emphasis on research and development, Circassia strives to bring breakthrough therapies to market, addressing unmet medical needs and providing better treatment options for patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

19 Patents

#75 in

#921 in United Kingdom

#31,670 in the World

...
GB

Circassia Limited

Forward Citations = 31

21 inventors:

goldMedal Roderick Peter Hafner (14 out of 29 patents)

silverMedal Paul Laidler (12 out of 12 patents)

bronzeMedal Mark Larche (12 out of 12 patents)

4.  Anthony Barrington Kay (3 out of 3 patents)

5.  Robyn Elizabeth O'Hehir (2 out of 10 patents)

Please report any incorrect information to support@idiyas.com
Loading…